{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T20:49:18Z","timestamp":1773434958558,"version":"3.50.1"},"reference-count":13,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2002,4]]},"DOI":"10.1067\/mjd.2002.119671","type":"journal-article","created":{"date-parts":[[2002,8,24]],"date-time":"2002-08-24T18:14:26Z","timestamp":1030212866000},"page":"541-544","source":"Crossref","is-referenced-by-count":49,"title":["Sulfasalazine for alopecia areata"],"prefix":"10.1067","volume":"46","author":[{"given":"Charles N.","family":"Ellis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret F.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"Voorhees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1067\/mjd.2002.119671_bib1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/sj.jidsp.5640212","article-title":"Alopecia areata is a T-lymphocyte mediated autoimmune disease: lesional human T-lymphocytes transfer alopecia areata to human skin grafts on SCID mice","volume":"4","author":"Gilhar","year":"1999","journal-title":"J Invest Dermatol Symp Proc"},{"key":"10.1067\/mjd.2002.119671_bib2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/sj.jidsp.5640218","article-title":"The potential role of cytokines and T cells in alopecia areata","volume":"4","author":"Hoffman","year":"1999","journal-title":"J Invest Dermatol Symp Proc"},{"key":"10.1067\/mjd.2002.119671_bib3","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/sj.jidsp.5640215","article-title":"Alopecia areata in families: association with the HLA locus","volume":"4","author":"de Andrade","year":"1999","journal-title":"J Invest Dermatol Symp Proc"},{"key":"10.1067\/mjd.2002.119671_bib4","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0190-9622(90)70032-D","article-title":"Oral cyclosporine for the treatment of alopecia areata: a clinical and immunohistochemical analysis","volume":"22","author":"Gupta","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2002.119671_bib5","first-page":"739","article-title":"Hair disorders","author":"Olsen","year":"1999"},{"key":"10.1067\/mjd.2002.119671_bib6","first-page":"487","article-title":"Sulfasalazine: I, an historical perspective","volume":"83","author":"Bachrach","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1067\/mjd.2002.119671_bib7","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/rheumatology\/36.3.382","article-title":"Sulphasalazine in the treatment of rheumatoid arthritis","volume":"36","author":"Box","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1067\/mjd.2002.119671_bib8","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1001\/archderm.1990.01670280071013","article-title":"Sulfasalazine improves psoriasis: a double-blind analysis","volume":"126","author":"Gupta","year":"1990","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1067\/mjd.2002.119671_bib9","first-page":"894","article-title":"Sulfasalazine therapy for psoriatic arthritis: a double-blind, placebo controlled trial","volume":"22","author":"Gupta","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1067\/mjd.2002.119671_bib10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/rheumatology\/XXXIV.suppl_4.7","article-title":"Sulphasalazine: mechanism of action in rheumatoid arthritis","volume":"34s","author":"Smedegard","year":"1995","journal-title":"Br Soc Rheumatol"},{"key":"10.1067\/mjd.2002.119671_bib11","first-page":"137","article-title":"Sulfasalazine: a review of its pharmacological properties and therapeutic efficacy in the treatment of rheumatoid arthritis","volume":"49","author":"Rains","year":"1995","journal-title":"Drug Evaluation"},{"key":"10.1067\/mjd.2002.119671_bib12","doi-asserted-by":"crossref","first-page":"406","DOI":"10.2165\/00003088-197601060-00002","article-title":"Clinical pharmacokinetics of sulphasalazine","volume":"1","author":"Das","year":"1976","journal-title":"Clin Pharmacokinetics"},{"key":"10.1067\/mjd.2002.119671_bib13","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0190-9622(99)70195-7","article-title":"Alopecia areata investigational assessment guidelines","volume":"40","author":"Olsen","year":"1999","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096220206382X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096220206382X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T10:58:24Z","timestamp":1557399504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019096220206382X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,4]]}},"alternative-id":["S019096220206382X"],"URL":"https:\/\/doi.org\/10.1067\/mjd.2002.119671","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2002,4]]}}}